1. Challenge

Demands from payors and regulators for differentiated products necessitates creative integration of available data/ information, with future trial data, to accelerate drug development in an efficient, cost effective and ethical manner.

Creative Pharmetheus

Advancing model informed drug development
  • Offers a broad range of fit for purpose analytical solutions, including data programming, across all phases of research and development (incorporating submission and post approval activities).
  • Has a flexible resource pool to accommodate varying needs, including modeling, training, interaction with regulatory bodies, expert advice and full-time equivalent support.
  • Has experience of, and expertise in, a broad range of therapeutic areas.

2. Challenge

Scientific rigor, quality, compliance and traceability are cornerstones in clinical drug development and regulatory submissions.This requires reliable technical solutions and experience to efficiently leverage MIDD in these settings.

Reliable Pharmetheus

When efficiency meets quality
  • Has robust processes for reproducibility and documentation of analysis results.
  • Has considerable experience of delivering submission ready reports..
  • Has an independent quality control (QC) collaboration to monitor and check on our deliverables.

3. Challenge

Drug development moves at a swift pace in an ever-changing competitive landscape and project teams are constantly facing new challenges, demanding a flexible, proactive and adaptive mindset

Flexible Pharmetheus

Transforming quality science to informed decisions
  • Offers a broad range of fit for purpose analytical solutions, including data programming, across all phases of research and development (incorporating submission and post approval activities).
  • Has a flexible resource pool to accommodate varying needs, including modeling, training, interaction with regulatory bodies, expert advice and full-time equivalent support.
  • Has experience of, and expertise in, a broad range of therapeutic areas.

Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions.

Our Communications

Latest news from Pharmetheus

We are active in the biosimilar area

Mechanism based pharmacometric analysis can be a powerful tool in the development of biosimilar drugs. Pharmetheus recently supported a client with evaluating the impact of study design and expected product differences on the power to demonstrate PK and PD similarity. Find out more in a recent paper by Ari Brekkan et al. AAPS J. 2019 Jul 8;21(5):85.

Welcome Ida Netterberg!

We are glad to announce that Ida Netterberg (MIDD consultant) is returning to Pharmetheus after recently defending her PhD thesis at Uppsala University. Ida’s thesis focused on pharmacometric evaluation of biomarkers to improve treatment in oncology. See Ida's bio here.

Welcome Ola Caster!

We are happy to welcome Ola Caster in our growing enabler team. Ola comes most recently from a position as a Senior Researcher at the Uppsala Monitoring Centre, where he worked primarily with methods for adverse effect detection and benefit-risk assessment in the post-marketing setting. He has more than ten years of experience from research in statistics and data science, including a PhD in Computer and Systems Sciences. See Ola's bio here.

Welcome Marie Karlsson!

The Pharmetheus team has recently been strengthened by our first dedicated Project Coordinator, Marie Karlsson. Marie has long prior experience in monitoring data processing and project management in software development. See Marie's bio here. Welcome!

ACoP in Orlando

Come meet us at ACoP in Orlando next week. Drop by our booth to discuss model informed drug development with our experts and leaders. There are still opportunities for free speed consulting, should you want input to your strategic or hands-on work.

Speed consulting at ACop 2019

This year, during the ACOP Meeting in Orlando, Pharmetheus will offer professional pharmacometric consulting sessions (~30 min), free of charge. Talk to us about Pharmacometrics, PBPK, Regulatory strategy, MIDD strategy, and much more! These sessions are open to everyone and independent of any current or future plans to use our services.

Services

Our services include quantitative analyses by scientists with extensive therapeutic area experience industry, academic and regularly settings.

Our team

Pharmetheus consultants and advisors present a unique collection of experiences and combination of skill sets.

Agneta Franksson

Board Member
Dr. Anders Kristoffersson, Consultant

Anders Kristoffersson

Consultant
Dr. Andrew Hooker, Advisor

Andrew Hooker

Advisor

Angela Äbelö

Consultant
Antonio Klaric, Analyst Consultant, System Administrator

Antonio Klaric

Analyst Consultant, System Administrator
Dr. Ari Brekkan, Consultant

Ari Brekkan

Consultant
Arnaud Gaby, Associate Consultant, Data Programmer

Arnaud Gaby

Associate Consultant, Data Programmer
Arnaud Pharasyn, Senior Consultant, IT Manager

Arnaud Pharasyn

Senior Consultant, IT Manager
Dr. Celine Sarr, Senior Consultant

Celine Sarr

Senior Consultant
Dr. Chayan Acharya, Senior Consultant

Chayan Acharya

Senior Consultant
Dr. Daniel Röshammar, Senior Consultant

Daniel Röshammar

Senior Consultant
Dr. Elin Matsson, Senior Consultant

Elin Matsson

Senior Consultant
Dr. Elodie Plan, Principal Consultant, Board Member

Elodie Plan

Principal Consultant, Board Member

Emma Ångström

Chief Financial Officer
Dr. Emma Hansson, Senior Consultant

Emma Hansson

Senior Consultant

Enrica Mezzalana

Consultant
Eric Sandström, Analyst Consultant, Systems Developer

Eric Sandström

Analyst Consultant, Systems Developer
Dr. Erik Sjögren, Senior Consultant

Erik Sjögren

Senior Consultant

Fredrik Alpsten

Board Member
Georges Etté, Associate Consultant, Data Programmer

Georges Etté

Associate Consultant, Data Programmer
Dr. Giovanni Smania, Consultant

Giovanni Smania

Consultant

Ida Netterberg

Consultant
Dr. Jakob Ribbing, Senior Consultant

Jakob Ribbing

Senior Consultant
Dr. Joakim Nyberg, Principal Consultant

Joakim Nyberg

Principal Consultant
Dr. Jurgen Langenhorst, Associate Consultant

Jurgen Langenhorst

Associate Consultant
Dr. Kajsa Harling, Consultant, Systems Development

Kajsa Harling

Consultant, Systems Development
Prof. Lena Friberg, Advisor

Lena Friberg

Advisor
Dr. Marcus Björnsson, Senior Consultant

Marcus Björnsson

Senior Consultant

Marie Karlsson

Project Coordinator
Dr. Marie Sandström, Chief Operations Officer, Deputy CEO

Marie Sandström

Chief Operations Officer, Deputy CEO
Markus Seltmann, Analyst Consultant, Systems Architecture

Markus Seltmann

Analyst Consultant, System Administrator
Dr. Martin Bergstrand, Principal Consultant, Board Member

Martin Bergstrand

Principal Consultant, Board Member
Dr. Martin Fransson, Consultant

Martin Fransson

Consultant

Mats Karlsson

Board Chair, Advisor
Dr. Mats Magnusson, Principal Consultant

Mats Magnusson

Principal Consultant
Dr. Moustafa Ibrahim, Associate Consultant

Moustafa Ibrahim

Associate Consultant
Dr. Niclas Jonsson, Principal Consultant

Niclas Jonsson

Principal Consultant

Ola Caster

Associate Consultant
Per Lundström, Administrative Assistant

Per Lundström

Administrative Assistant
Dr. Peter Milligan, Chief Executive Officer

Peter Milligan

Chief Executive Officer
Dr. Peteris Prusis, Associate Consultant, Data Programmer

Peteris Prusis

Associate Consultant, Data Programmer

Qing Xi Ooi

Associate Consultant
Richard Anziano, Principal Consultant, Chief Statistician

Richard Anziano

Principal Consultant, Chief Statistician
Dr. Robin Svensson, Associate Consultant

Robin Svensson

Associate Consultant
Dr. Sofia Friberg Hietala, Senior Consultant

Sofia Friberg Hietala

Senior Consultant

Request our servies

If you are interested in our services, please fill out the form below

How we work

Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.